Truenat MTB-INH is the only point-of-care Real-Time PCR test that aids in diagnosing (Hr-TB) as the frontline test
Goa-based Molbio Diagnostics has launched Truenat MTB-INH for testing the presence of isoniazid resistance in Mycobacterium tuberculosis infection. The test is validated by ICMR and approved by CDSCO. It can provide sample-to-test results in an hour.
Truenat MTB-INH will immediately be available to the existing 3300 PHCs/CHCs using Truenat under the National TB Elimination Program (NTEP) as per program needs. Truenat MTB-INH is also expected to play a major role internationally, in high TB-burden countries as well as countries that already have a policy in place for INH testing on all TB-positive samples.
Sriram Natarajan, CEO, Founder, and Director, of Molbio Diagnostics, said, “The current launch of Truenat MTB-INH further strengthens Molbio’s product portfolio of providing complete testing solutions through the Truenat platform. Once introduced in all the blocks, every TB patient will have access to MDR TB testing at the same TB testing centre with reporting on the same day so correct treatment can also begin on the same day thus enabling better treatment outcomes and bringing down the disease spread. Molbio will continue to bring innovative solutions for better patient management and eradication of the disease.
Dr Chandrasekhar Nair, CTO, and Director, of Molbio Diagnostics, said, “Molecular methods such as Polymerase Chain Reaction (PCR) or Real-Time PCR are revolutionizing disease diagnosis and management and Truenat has been a game changer in this regard as a point of care molecular platform that offers over 40 tests right at the point of need. The launch of the Truenat MTB INH test is another milestone in our TB portfolio.”
Truenat is a point-of-care, portable, battery-operated, IoT-enabled, multi-disease, Real-Time PCR platform with a sample-to-result time of less than 1 hour. The platform can test over 40 diseases, such as COVID-19, TB, HCV, HBV, HIV, HPV, dengue, malaria, influenza, herpes and typhoid.